| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_536da7f074da000d866ec0cb70f8a356
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_956d91778fc1128ec4f119e58f285c3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee38ecee23a11801d601aff1702f737a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93122d7d06e2172055fcb9ae76b8a581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a10f8b7d5245b46f60536e02e26eb23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79650bd1c2458b782018052eb0f7e4d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9542005b776ed6b1dec0d71e1166d10d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eff8557d3ad2eca358e5b0cf0b766e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc47eb8038c3e0d8882151480560b53a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fac01a8dd0ea3d4aa715bc5bb387584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bdad537528e1425ca0c083f41547a6d |
| publicationDate |
2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011319472-A1 |
| titleOfInvention |
Methods of prognosticating and treating ewing sarcoma/pnet and other neoplasms |
| abstract |
A method of distinguishing between Ewing sarcoma patients having a good prognosis relative to those having a poor prognosis by screening for specific genomic copy number alterations (CNA) isolated and/or measuring denticleless homolog (Drosophila) (DTL) protein levels from the tumors of patients diagnosed with Ewing Sarcoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10369104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017143630-A1 |
| priorityDate |
2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |